These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 32020439)
1. The quality assessment of the Japanese Adverse Drug Event Report database using vigiGrade. Tsuchiya M; Obara T; Miyazaki M; Noda A; Takamura C; Mano N Int J Clin Pharm; 2020 Apr; 42(2):728-736. PubMed ID: 32020439 [TBL] [Abstract][Full Text] [Related]
2. Quality evaluation of the Japanese Adverse Drug Event Report database (JADER). Tsuchiya M; Obara T; Sakai T; Nomura K; Takamura C; Mano N Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):173-181. PubMed ID: 31823506 [TBL] [Abstract][Full Text] [Related]
3. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues. Bergvall T; Norén GN; Lindquist M Drug Saf; 2014 Jan; 37(1):65-77. PubMed ID: 24343765 [TBL] [Abstract][Full Text] [Related]
4. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study. Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025 [TBL] [Abstract][Full Text] [Related]
5. Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance. Lee I; Jokinen JD; Crawford SY; Calip GS; Kilpatrick RD; Lee TA Ther Innov Regul Sci; 2021 Jan; 55(1):142-151. PubMed ID: 32720297 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study. Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database. Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database. Chisaki Y; Aoji S; Yano Y Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626 [TBL] [Abstract][Full Text] [Related]
9. Differential completeness of spontaneous adverse event reports among hospitals/clinics, pharmacies, consumers, and pharmaceutical companies in South Korea. Oh IS; Baek YH; Kim HJ; Lee M; Shin JY PLoS One; 2019; 14(2):e0212336. PubMed ID: 30763386 [TBL] [Abstract][Full Text] [Related]
10. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports. Wakao R; Taavola H; Sandberg L; Iwasa E; Soejima S; Chandler R; Norén GN Drug Saf; 2019 Dec; 42(12):1487-1498. PubMed ID: 31559542 [TBL] [Abstract][Full Text] [Related]
11. Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain-differences between regional pharmacovigilance centres and pharmaceutical industry. Fernandez-Fernandez C; Lázaro-Bengoa E; Fernández-Antón E; Quiroga-González L; Montero Corominas D Eur J Clin Pharmacol; 2020 Aug; 76(8):1175-1181. PubMed ID: 32447435 [TBL] [Abstract][Full Text] [Related]
12. Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection. Plessis L; Gómez A; García N; Cereza G; Figueras A Eur J Clin Pharmacol; 2017 Jun; 73(6):751-758. PubMed ID: 28251276 [TBL] [Abstract][Full Text] [Related]
13. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database. Impicciatore P; Mucci M Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409 [TBL] [Abstract][Full Text] [Related]
14. Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database. Sato K; Mano T; Iwata A; Toda T J Alzheimers Dis; 2021; 82(3):1333-1344. PubMed ID: 34151816 [TBL] [Abstract][Full Text] [Related]
15. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study. Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236 [TBL] [Abstract][Full Text] [Related]
16. [Completeness of pharmacovigilance reporting in general medicine in France.]. Humbert X; Jacquot J; Alexandre J; Sassier M; Robin N; Pageot C; Kheloufi F; Joyau C; Coquerel A; Durrieu G; Fedrizzi S Sante Publique; 2019; Vol. 31(4):561-566. PubMed ID: 31959257 [TBL] [Abstract][Full Text] [Related]
17. [Role and Applicability of Spontaneous Reporting Databases in Medical Big Data]. Sakai T Yakugaku Zasshi; 2021; 141(2):165-168. PubMed ID: 33518634 [TBL] [Abstract][Full Text] [Related]
18. Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations. Ribeiro A; Lima S; Zampieri ME; Peinado M; Figueras A Expert Opin Drug Saf; 2017 Dec; 16(12):1329-1334. PubMed ID: 28817316 [TBL] [Abstract][Full Text] [Related]
19. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database. Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819 [TBL] [Abstract][Full Text] [Related]
20. Pharmacovigilance Assessment of Drug-Induced Acute Pancreatitis Using a Spontaneous Reporting Database. Niinomi I; Hosohata K; Oyama S; Inada A; Wakabayashi T; Iwanaga K Int J Toxicol; 2019; 38(6):487-492. PubMed ID: 31470743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]